Top Premarket Gainers

MT Newswires Live2025-04-14

Third Harmonic Bio (THRD) shares rose 40% in recent Monday premarket activity, after saying its board has approved a plan for the company's liquidation and dissolution and will seek stockholder approval for the plan at its annual meeting on June 5.

Verve Therapeutics (VERV) stock climbed 23% after it reported positive initial results from its phase 1b Heart-2 clinical study to evaluate gene editing therapy VERVE-102 for patients with heterozygous familial hypercholesterolemia and premature coronary artery disease.

Palatin Technologies (PTN) shares were up 22% after the biopharmaceutical company said it appealed the New York Stock Exchange's decision to delist its common shares.

Apple (AAPL) shares rose 6.4% after KeyBanc upgraded it to sector weight from underweight, followed by a Counterpoint Research report saying that the tech giant was Q1's top seller in the global smartphone market with a 19% market share, aided by the launch of the iPhone 16e and continued growth in its non-core markets.

BP (BP) stock gained more than 3% after the energy giant said it has made an oil discovery at the Far South prospect in deep water in the 'Gulf of America.'

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment